Taxane
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
654 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 36 | 168 | 92 | 9 | 73 | 355 |
| Neoplasms | D009369 | — | C80 | 34 | 21 | 4 | 1 | 8 | 61 |
| Peripheral nervous system diseases | D010523 | — | G64 | 6 | 10 | 2 | 2 | 38 | 56 |
| Triple negative breast neoplasms | D064726 | — | — | 5 | 21 | 14 | 2 | 8 | 48 |
| Recurrence | D012008 | — | — | 3 | 11 | 3 | 1 | 1 | 16 |
| Male breast neoplasms | D018567 | — | — | — | 4 | 1 | 1 | 5 | 11 |
| Head and neck neoplasms | D006258 | — | — | 2 | 5 | — | 1 | — | 8 |
| Syndrome | D013577 | — | — | 2 | 1 | — | 1 | — | 4 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | 1 | — | 2 | — | 4 |
| Acrodynia | D000170 | EFO_1001756 | — | — | 1 | — | 1 | — | 2 |
Show 1 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 22 | 38 | 10 | — | 7 | 69 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 8 | 22 | 9 | — | 9 | 46 |
| Carcinoma | D002277 | — | C80.0 | 10 | 23 | 6 | — | 6 | 41 |
| Non-small-cell lung carcinoma | D002289 | — | — | 8 | 26 | 9 | — | 2 | 41 |
| Lung neoplasms | D008175 | — | C34.90 | 6 | 26 | 8 | — | 2 | 38 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 6 | 20 | 8 | — | 5 | 36 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 13 | 16 | 5 | — | 1 | 31 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 3 | 13 | 9 | — | 1 | 25 |
| Fallopian tube neoplasms | D005185 | — | — | 4 | 11 | 7 | — | 4 | 24 |
| Adenocarcinoma | D000230 | — | — | 6 | 11 | 4 | — | 4 | 23 |
Show 47 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 5 | 1 | — | — | 3 | 9 |
| Esophageal neoplasms | D004938 | — | C15 | 1 | 4 | — | — | 4 | 9 |
| Small cell lung carcinoma | D055752 | — | — | 3 | 4 | — | — | — | 6 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 1 | — | — | 1 | 5 |
| Glioblastoma | D005909 | EFO_0000515 | — | 2 | 4 | — | — | — | 4 |
| Small cell carcinoma | D018288 | — | — | 1 | 4 | — | — | — | 4 |
| Lymphoma | D008223 | — | C85.9 | 2 | 1 | — | — | — | 3 |
| Female genital neoplasms | D005833 | — | — | 1 | 2 | — | — | 1 | 3 |
| Invasive hydatidiform mole | D002820 | — | D39.2 | — | 1 | — | — | 2 | 3 |
| Sarcoma | D012509 | — | — | 1 | 3 | — | — | — | 3 |
Show 44 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic ductal carcinoma | D021441 | — | — | 3 | — | — | — | 1 | 4 |
| Hodgkin disease | D006689 | — | C81 | 3 | — | — | — | — | 3 |
| Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | — | 2 |
| Multiple myeloma | D009101 | — | C90.0 | 1 | — | — | — | 1 | 2 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 2 | — | — | — | — | 2 |
| Urologic neoplasms | D014571 | — | C64-C68 | 2 | — | — | — | — | 2 |
| Leukemia | D007938 | — | C95 | 1 | — | — | — | — | 1 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 1 | — | — | — | — | 1 |
Show 27 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alopecia | D000505 | — | L64 | — | — | — | — | 4 | 4 |
| Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 3 | 3 |
| Nervous system diseases | D009422 | — | G00-G99 | — | — | — | — | 3 | 3 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 2 | 2 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | — | — | 1 | 1 |
| Biliary tract neoplasms | D001661 | — | C24.9 | — | — | — | — | 1 | 1 |
| Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | — | — | — | — | 1 | 1 |
| Peripheral vascular diseases | D016491 | EFO_0003875 | I73.9 | — | — | — | — | 1 | 1 |
| Urogenital neoplasms | D014565 | EFO_0003863 | D07 | — | — | — | — | 1 | 1 |
| Male genital diseases | D005832 | EFO_0009555 | N50.9 | — | — | — | — | 1 | 1 |
Show 29 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
60 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use